Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2016-09-15

Original market date: See footnote 1

2016-09-15

Product name:

NXSTAGE PUREFLOW SOLUTION RFP-207-CAN

DIN:

02443287 Electronic product monograph is not available

Company: 

NXSTAGE MEDICAL INC
350 Merrimack Street
Lawrence
Massachusetts
United States  01843

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Dialysis

Number of active ingredient(s):

6

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

40:34.00* See footnote 6   HEMODIALYSIS SOLUTION

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05Z  HEMODIALYTICS AND HEMOFILTRATES

Active ingredient group (AIG) number:See footnote 5

0633087009

List of active ingredient(s)
Active ingredient(s) Strength
CALCIUM CHLORIDE 0.221 G / L
DEXTROSE 1.1 G / L
MAGNESIUM CHLORIDE 0.102 G / L
POTASSIUM CHLORIDE 0.075 G / L
SODIUM CHLORIDE 5.552 G / L
SODIUM LACTATE 8.408 G / L

Application information

Related information

Contact us

Version 3.9.0
Date modified: